| A Study of IW-6463 in Healthy Volunteers (NCT03856827) | Tisento Therapeutics | 2019-02-06 |
| Placebo-controlled Study to Determine the Safety and Tolerability of Subcutaneous Doses of Sevuparin (NCT03853421) | Modus Therapeutics AB | 2019-02-06 |
| CFI-402257 in Combination With Paclitaxel in Patients With Advanced/Metastatic HER2-Negative Breast Cancer (NCT03568422) | Canadian Cancer Trials Group | 2019-02-05 |
| A Study to Assess the Reaction of Body for Four Different Formulations of AZD9977 (Part A) and Influence of Food and Lower Dose of a Selected Formulation (Part B) in Healthy Male Subjects (NCT03804645) | AstraZeneca | 2019-02-05 |
| First-in-Human Study of EOS100850 (Inupadenant) in Patients with Cancer (NCT03873883) | iTeos Therapeutics | 2019-02-05 |
| PIPAC for the Treatment of Colorectal Peritoneal Metastases (NCT03868228) | Imperial College London | 2019-02-05 |
| A Safety Study of LY3372689 Given By Mouth to Healthy Participants (NCT03819270) | Eli Lilly and Company | 2019-02-05 |
| Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPC (NCT03792841) | Amgen | 2019-02-05 |
| Safety and Efficacy of Microbial Ecosystem Therapeutic-2 (MET-2) in Patients With Ulcerative Colitis (UC) (NCT03832400) | NuBiyota | 2019-02-04 |
| Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas (NCT03598998) | City of Hope Medical Center | 2019-02-04 |
| A Phase 1 Study of FOR46 in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (NCT03575819) | Fortis Therapeutics, Inc. | 2019-02-04 |
| A Study of Mobocertinib in Japanese Adults With Non-Small Cell Lung Cancer (NCT03807778) | Takeda | 2019-02-04 |
| Safety and Antitumor Activity Study of Loncastuximab Tesirine and Durvalumab in Diffuse Large B-Cell, Mantle Cell, or Follicular Lymphoma (NCT03685344) | ADC Therapeutics S.A. | 2019-02-04 |
| Testing the Safety of Different Doses of Olaparib Given Radium-223 for Men With Advanced Prostate Cancer With Bone Metastasis (NCT03317392) | National Cancer Institute (NCI) | 2019-02-04 |
| AO-176 in Multiple Solid Tumor Malignancies (NCT03834948) | Arch Oncology | 2019-02-04 |
| Vagal Nerve Stimulation to Probe Inflammation and Brain in Post-traumatic Stress (NCT03858985) | VA Office of Research and Development | 2019-02-04 |
| Effects of Nicotine in Tobacco Smokers (NCT03651869) | University of Southern California | 2019-02-04 |
| Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714. (NCT03759522) | University of Alabama at Birmingham | 2019-02-03 |
| Treatment of Acute Myeloid Leukemia With Arsenic and All-trans Retinoid Acid (NCT05297123) | First Affiliated Hospital Xi'an Jiaotong University | 2019-02-03 |
| Autologous Umbilical Cord Blood Treatment of Neonate With CHD (NCT03558269) | Sheba Medical Center | 2019-02-01 |
| Leucine Supplementation in Sarcopenic Older Individuals (NCT03831399) | University of Valencia | 2019-02-01 |
| Lung and Diaphragm-Protective Ventilation by Means of Assessing Respiratory Work (NCT03612583) | University Health Network, Toronto | 2019-02-01 |
| CD19/20 Bispecific Nanobody-derived CAR-T Cells in B Cell Lymphoma (NCT03881761) | Henan Cancer Hospital | 2019-02-01 |
| Transcranial Direct Current Stimulation (tDCS) Augments the Effects of Gamified, Mobile Attention Bias Modification (NCT04348812) | Hunter College of City University of New York | 2019-02-01 |
| A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1801 in Healthy Subjects (NCT03826641) | Hanmi Pharmaceutical Company Limited | 2019-02-01 |
| Reliability of [18F]-FTC-146 Brain Uptake in Healthy Controls (NCT03649555) | Stanford University | 2019-02-01 |
| Steroid Therapy in Acute Bronchiolitis A New Old Line of Therapy. (NCT03436225) | Assiut University | 2019-02-01 |
| A Study to Determine the Bioavailability of Various Formulations of GDC-0134 in Healthy Female Participants of Non-Childbearing Potential (NCT03807739) | Genentech, Inc. | 2019-02-01 |
| rTMS for Emotional Difficulties in Verterans (NCT03749967) | VA Office of Research and Development | 2019-02-01 |
| Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Cancers (NCT03748186) | Sutro Biopharma, Inc. | 2019-02-01 |
| Exploring Cancer-Associated Thromboembolism Prognosis Biomarkers and Polymorphisms (NCT06065592) | Lebanese University | 2019-02-01 |
| Ceritinib Plus Docetaxel in ALK-Negative, EGFR WT Advanced NSCLC (NCT03611738) | H. Lee Moffitt Cancer Center and Research Institute | 2019-02-01 |
| Ultrasound Guided Platelet Rich Plasma Injections for Post Traumatic Greater Occipital Neuralgia (NCT04051203) | University of Calgary | 2019-02-01 |
| FMISO PET/CT Imaging Trial for Assessing Hypoxia in Soft Tissue Sarcomas (NCT03730077) | University of Pennsylvania | 2019-02-01 |
| MEBO Ointment and Hyaluronic Acid Gel in the Management of Pain After Free Gingival Graft Harvesting (NCT03728244) | Cairo University | 2019-02-01 |
| UCMSCs as Front-line Approach of Treatment for Patients With aGVHD (NCT03847844) | Cytopeutics Sdn. Bhd. | 2019-02-01 |
| A Study of LY3405105 in Participants With Advanced Cancer (NCT03770494) | Eli Lilly and Company | 2019-01-31 |
| Hu8F4 in Treating Patients With Advanced Hematologic Malignancies (NCT02530034) | M.D. Anderson Cancer Center | 2019-01-31 |
| Ga-DOTATATE PET for Phosphaturic Mesenchymal Tumors in Patients With Tumor Induced Osteomalacia (NCT03736564) | Mayo Clinic | 2019-01-31 |
| End-stage Renal Disease (ESRD) Pilot Study (NCT03787368) | Bayer | 2019-01-31 |
| Needle-Knife Fistulotomy Vs. Standard Cannulation Trial (NCT06694038) | Thomas Jefferson University | 2019-01-31 |
| Tobramycin Administered at the Beginning of Dialysis (NCT03904836) | Maisonneuve-Rosemont Hospital | 2019-01-31 |
| Drug Interaction Study Between Dorzagliatin and Sitagliptin (NCT03790839) | Hua Medicine Limited | 2019-01-31 |
| A Study in Healthy Men to Measure the Amount of BI 730357 in the Blood When Taken as a Tablet (NCT03804671) | Boehringer Ingelheim | 2019-01-31 |
| A Trial of Single- and Multiple-doses of Aripiprazole in Adult Subjects With Schizophrenia or Bipolar I Disorder (NCT03854409) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2019-01-31 |
| A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Upadacitinib in Pediatric Participants With Severe Atopic Dermatitis (NCT03646604) | AbbVie | 2019-01-31 |
| Study of Safety and Efficacy of Novel Immunotherapy Combinations in Patients With Triple Negative Breast Cancer (TNBC). (NCT03742349) | Novartis Pharmaceuticals | 2019-01-31 |
| Phase 1 Study in Patients With Advanced and/or Refractory Solid Malignancies to Evaluate the Safety of ATOR-1015 (NCT03782467) | Alligator Bioscience AB | 2019-01-30 |
| Safety, Tolerability and Pharmacokinetics of AD16 Tablets in Adult Healthy Subjects After Single Administration (NCT05787028) | South China Center For Innovative Pharmaceuticals | 2019-01-30 |
| Ribociclib in Combination With Everolimus and Dexamethasone in Relapsed ALL (NCT03740334) | Dana-Farber Cancer Institute | 2019-01-30 |
| A Randomized Placebo-controlled Multicenter Trial to Evaluate the Efficacy and Safety of JTR-161, Allogeneic Human Dental Pulp Stem Cell, in Patients With Acute Ischemic stRoke (J-REPAIR) (NCT04608838) | Teijin Pharma Limited | 2019-01-30 |
| Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors (NCT03734588) | Spark Therapeutics, Inc. | 2019-01-30 |
| Trametinib and Hydroxychloroquine in Treating Patients With Pancreatic Cancer (NCT03825289) | University of Utah | 2019-01-30 |
| Stereotactic Radiation and Nivolumab in the Management of Metastatic Breast Cancer Brain Metastases (NCT03807765) | H. Lee Moffitt Cancer Center and Research Institute | 2019-01-30 |
| B-MAD Chemotherapy in Newly-diagnosed Extranodal NK/ T-cell Lymphoma (NCT03246750) | The Thai Lymphoma Study Group | 2019-01-30 |
| Phase I-II Study of Intratumoral Urelumab Combined With Nivolumab in Patients With Solid Tumors (NCT03792724) | Clinica Universidad de Navarra, Universidad de Navarra | 2019-01-30 |
| A Study in Healthy Men to Find Out How Well Different Doses of BI 764122 Are Tolerated and Whether Food Affects the Amount of BI 764122 in the Blood (NCT03794323) | Boehringer Ingelheim | 2019-01-30 |
| Biomarker Assessments of Leukine During Treatment of Parkinson's Disease (NCT03790670) | University of Nebraska | 2019-01-30 |
| A Bioequivalence (BE) Study of TAK-438 Orally Disintegrating (OD) Tablet (NCT03808493) | Takeda | 2019-01-30 |
| [68Ga]DOTATATE-PET/MRI in Hepatocellular Carcinoma (NCT03648073) | University of Alabama at Birmingham | 2019-01-30 |
| Effect of Food on the Bioavailability of 30 mg Estetrol (E4) Tablet in Healthy Postmenopausal Female Volunteers (NCT03798197) | Donesta Bioscience | 2019-01-30 |
| Nivolumab and Pomalidomide in Treating Patients With Relapsed or Refractory Central Nervous System Diffuse Large B Cell Lymphoma or Primary Vitreoretinal Diffuse Large B Cell Lymphoma (NCT03798314) | Mayo Clinic | 2019-01-30 |
| Study of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck Cancer (NCT03809624) | Inhibrx Biosciences, Inc | 2019-01-30 |
| First-In-Human Study to Evaluate Safety And Pharmacokinetics of Single Escalating Doses of BCD-147 (Bispecific Anti-HER2/HER2 Antibody) in Healthy Subjects (NCT03912441) | Biocad | 2019-01-30 |
| Study of Ixekizumab in Healthy Participants (NCT03848403) | Eli Lilly and Company | 2019-01-29 |
| RAmucirumab Combined wIth Standard Nab-paclitaxel and Gemcitabine as First-line Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma (NCT03745430) | Hellenic Cooperative Oncology Group | 2019-01-29 |
| A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of AMG 592 in Healthy Japanese Participants (NCT05885451) | Amgen | 2019-01-29 |
| A Study of Ixekizumab in Healthy Participants (NCT03848416) | Eli Lilly and Company | 2019-01-29 |
| Dapagliflozin In Alzheimer's Disease (NCT03801642) | Jeff Burns, MD | 2019-01-29 |
| A Pilot Study of the Combination of Entinostat With Capecitabine in High Risk Breast Cancer After Neo-adjuvant Therapy (NCT03473639) | University of Virginia | 2019-01-29 |
| A Study of Effects of Selpercatinib (LY3527723) on Repaglinide in Healthy Participants (NCT05469113) | Eli Lilly and Company | 2019-01-29 |
| Adult Healthy Volunteers Study to Evaluate ALPN-101 Safety (NCT03748836) | Alpine Immune Sciences, Inc. | 2019-01-29 |
| Study of Intravenous ATYR1923 (Efzofitimod) for Pulmonary Sarcoidosis (NCT03824392) | aTyr Pharma, Inc. | 2019-01-29 |
| Personalized Neo-antigen Vaccine in Advanced Solid Tumors (NeoPepVac) (NCT03715985) | Herlev Hospital | 2019-01-28 |
| Diflucan Bioequivalence Study For Transferring The Manufacture (NCT03821480) | Pfizer | 2019-01-28 |
| A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced Malignancies (NCT03829501) | Kymab Limited | 2019-01-28 |
| Safety, Tolerability and Pharmacokinetics of KX826 in Healthy Male Subjects With Androgenetic Alopecia Following Topical Single Ascending Dose Administration (NCT04984707) | Suzhou Kintor Pharmaceutical Inc, | 2019-01-28 |
| Systemic Immune Checkpoint Blockade and Intraperitoneal Chemo-Immunotherapy in Recurrent Ovarian Cancer (NCT03734692) | Robert Edwards | 2019-01-28 |
| Gemcitabine, Docetaxel, and Hydroxychloroquine in Treating Participants With Recurrent or Refractory Osteosarcoma (NCT03598595) | M.D. Anderson Cancer Center | 2019-01-28 |
| Melanoma Checkpoint and Gut Microbiome Alteration With Microbiome Intervention (NCT03817125) | Parker Institute for Cancer Immunotherapy | 2019-01-28 |
| A Study to Test How Food Influences the Amount of BI 1323495 in the Blood of Healthy Men (NCT03802331) | Boehringer Ingelheim | 2019-01-28 |
| Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 Under Fed Condition (NCT03849339) | Chong Kun Dang Pharmaceutical | 2019-01-28 |
| Prevention of Sepsis-related Organ Dysfunction With Allocetra-OTS (NCT03925857) | Enlivex Therapeutics Ltd. | 2019-01-27 |
| Evaluation of Cerebral Small Vessel Disease in Patient With Primary Aldosteronism (NCT03821571) | National Taiwan University Hospital | 2019-01-25 |
| Vaccination of Triple Negative Breast Cancer Patients (NCT02938442) | University of Arkansas | 2019-01-25 |
| Daratumumab, Bortezomib, and Dexamethasone With or Without Venetoclax in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT03701321) | National Cancer Institute (NCI) | 2019-01-25 |
| Assessment of Gut Absorption of Experimental Medication BMS-986165 in Healthy Males (NCT03873415) | Bristol-Myers Squibb | 2019-01-25 |
| Venetoclax and Quizartinib in Treating Patients With FLT3-mutated Recurrent or Refractory Acute Myeloid Leukemia (NCT03735875) | M.D. Anderson Cancer Center | 2019-01-25 |
| Safety and Pharmacokinetics of the Combination Broadly Neutralizing Antibodies, 3BNC117-LS-J and 10-1074-LS-J, in Healthy American and African Adults (NCT04173819) | International AIDS Vaccine Initiative | 2019-01-25 |
| A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors (NCT03734913) | Guangdong Zhongsheng Pharmaceutical Co., Ltd. | 2019-01-25 |
| A Bioequivalence Study Testing Two Formulations of Sotagliflozin in Healthy Male and Female Subjects Under Fasted Conditions (NCT03776227) | Sanofi | 2019-01-25 |
| Treatment of Vitamin D Deficiency With Large Bolus Cholecalciferol (NCT04120064) | Parkview Medical Center | 2019-01-25 |
| CYC065 CDK Inhibitor and Venetoclax Study in Relapsed/Refractory CLL (NCT03739554) | Cyclacel Pharmaceuticals, Inc. | 2019-01-25 |
| SHR-1701 in Subjects With Metastatic or Locally Advanced Solid Tumors (NCT03774979) | Jiangsu HengRui Medicine Co., Ltd. | 2019-01-24 |
| A Single Ascending Dose Study in Adults (Stage 1) and Single Ascending Dose-Finding Study (Stage 2) in Elderly Subjects With ASP3772, A Pneumococcal Vaccine (NCT03803202) | GlaxoSmithKline | 2019-01-24 |
| Induced Suppression of Platelets Activity in Aneurysmal SAH Management (iSPASM) (NCT03691727) | David Hasan | 2019-01-24 |
| Evaluate the Efficacy and Safety of 'Immuncell-LC' in Patients Undergoing Liver Transplantation (NCT03983967) | GC Cell Corporation | 2019-01-24 |
| Study to Assess the Safety and Pharmacokinetic (PK) of CTP-692 in Healthy Volunteers (NCT03830463) | Concert Pharmaceuticals | 2019-01-24 |
| ALRN-6924 and Paclitaxel in Treating Patients With Advanced, Metastatic, or Unresectable Solid Tumors (NCT03725436) | M.D. Anderson Cancer Center | 2019-01-24 |
| Study to Compare the Effect of the Formulations (Orally Disintegrating Tablet and Film-coated Tablet) on Bioequivalence of Drug Rivaroxaban (Xarelto) at Dose of 10 mg in Japanese Healthy Male Adult Subjects (NCT04511611) | Bayer | 2019-01-24 |